The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Open accessAbstract
Background: Dietary intake of fruit and vegetables is associated with lower incidence of hypertension, but the mechanisms involved have not been elucidated. Here, we evaluated the effect of a high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and the prevention of cardiovascular disease. Methods: Gut microbiome, cardiorenal structure/function, and blood pressure were examined in sham and mineralocorticoid excess–treated mice with a control diet, high-fiber diet, or acetate supplementation. We also determined the renal and cardiac transcriptome of mice treated with the different diets. Results: We found that high consumption of fiber modified the gut microbiota populations and increased the abundance of acetate-producing bacteria independently of mineralocorticoid excess. Both fiber and acetate decreased gut dysbiosis, measured by the ratio of Firmicutes to Bacteroidetes, and increased the prevalence of Bacteroides acidifaciens . Compared with mineralocorticoid-excess mice fed a control diet, both high-fiber diet and acetate supplementation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ventricular hypertrophy. Acetate had similar effects and markedly reduced renal fibrosis. Transcriptome analyses showed that the protective effects of high fiber and acetate were accompanied by the downregulation of cardiac and renal Egr1 , a master cardiovascular regulator involved in cardiac hypertrophy, cardiorenal fibrosis, and inflammation. We also observed the upregulation of a network of genes involved in circadian rhythm in both tissues and downregulation of the renin-angiotensin system in the kidney and mitogen-activated protein kinase signaling in the heart. Conclusions: A diet high in fiber led to changes in the gut microbiota that played a protective role in the development of cardiovascular disease. The favorable effects of fiber may be explained by the generation and distribution of one of the main metabolites of the gut microbiota, the short-chain fatty acid acetate. Acetate effected several molecular changes associated with improved cardiovascular health and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One example includes a recent rodent hypertension study in which either a high-fiber diet (a prebiotic) or acetic acid alone (a gut microbial product) resulted in reduced blood pressure and adverse cardiac remodeling168.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [168]
In the citing paper
“A significant proportion of the SCFAs produced in the distal bowel is reabsorbed from the gut lumen by facilitated apical solute transport via multiple different transporters114–117 as well as via passive (concentration-dependent) diffusion118.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [118]
In the citing paper
“Finally, studies in animal models and in patients with hypertension have reported that interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects87,92–99.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
In the citing paper
“In DOCA-salt hypertensive mice, a high-fibre diet led to substantial reductions in both SBP and DBP (~20 mmHg)95.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1038/mi.2016.1042 · DOI
Cited by
Sorted by citations
Items 101–200 of 998
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2021) · Antioxidants · doi:10.3390/antiox10050784 · Cited by 144
Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 143
Health benefit of vegetable/fruit juice-based diet: Role of microbiome
Henning, S. M., Yang, J., Shao, P., Lee, R.-P., Huang, J., Ly, A., Hsu, M., Lu, Q., Thames, G., Heber, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02200-6 · Cited by 136
Timing the Microbes: The Circadian Rhythm of the Gut Microbiome
Liang, X., & FitzGerald, G. A. (2017) · Journal of Biological Rhythms · doi:10.1177/0748730417729066 · Cited by 132
Muralitharan, R. R., Jama, H. A., Xie, L., Peh, A., Snelson, M., & Marques, F. Z. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14473 · Cited by 131
Self-citationRole of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A. U., Ullah, K., Ahmad, W., & Wang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321395 · Cited by 145
Coronary artery disease is associated with an altered gut microbiome composition
Toya, T., Corban, M., Marietta, E. V., Horwath, I. E., Lerman, L. O., Murray, J. A., & Lerman, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227147 · Cited by 131
Ravassa, S., López, B., Treibel, T. A., José, G. S., Losada-Fuentenebro, B., Tapia, L., Bayés‐Genís, A., Díez, J., & González, A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101194 · Cited by 139
Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Yang, F., Chen, H., Gao, Y., An, N., Li, X., Pan, X., Yang, X., Tian, L., Sun, J., Xiong, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110503 · Cited by 135
Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production
Nowland, T. L., Plush, K. J., BARTON, M. D., & Kirkwood, R. N. (2019) · Animals · doi:10.3390/ani9030076 · Cited by 136
Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension
Zubcevic, J. A., Richards, E. M., Yang, T., Kim, S., Sumners, C., Pepine, C. J., & Raizada, M. K. (2019) · Circulation Research · doi:10.1161/circresaha.119.313965 · Cited by 126
Jia, Q., Wang, L., Zhang, X., Ding, Y., Li, H., Yang, Y., Zhang, A., Li, Y., Lv, S., & Zhang, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104552 · Cited by 125
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 132
Recent advances in modulation of cardiovascular diseases by the gut microbiota
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00698-6 · Cited by 121
Nakajima, A., Kaga, N., Nakanishi, Y., Ohno, H., Miyamoto, J., Kimura, I., Hori, S., Sasaki, T., Hiramatsu, K., Okumura, K., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700248 · Cited by 120
Fermented Foods: Their Health-Promoting Components and Potential Effects on Gut Microbiota
Shah, A. M., Tarfeen, N., Mohamed, H., & Song, Y. (2023) · Fermentation · doi:10.3390/fermentation9020118 · Cited by 146
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
Jia, Q., Li, H., Zhou, H., Zhang, X., Zhang, A., Xie, Y., Li, Y., Lv, S., & Zhang, J. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/5164298 · Cited by 119
Bai, Y., Li, Y., Marion, T. N., Tong, Y., Zaiss, M. M., Tang, Z., Zhang, Q., Liu, Y., & Luo, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102564 · Cited by 121
Magliocca, G., Mone, P., Iorio, B. R. D., Heidland, A., & Marzocco, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105354 · Cited by 130
Shen, H., Zhou, L., Zhang, H., Yang, Y., Jiang, L., Wu, D., Shu, H., Zhang, H., Xie, L., Zhou, K., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.008 · Cited by 125
Moffett, J. R., Puthillathu, N., Vengilote, R., Jaworski, D. M., & Namboodiri, A. M. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.580171 · Cited by 125
Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
Robles‐Vera, I., Toral, M., de la Visitación, N., Aguilera-Sánchez, N., Redondo, J. M., & Duarte, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00277 · Cited by 118
Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901080r · Cited by 116
Self-citationGut microbial metabolites SCFAs and chronic kidney disease
Meng, H., Wei, W., Zhang, Y., Xiang, Z., Peng, D., Kasimumali, A., & Rong, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04974-6 · Cited by 121
Gut Microbiome and Neuroinflammation in Hypertension
Richards, E. M., Li, J., Stevens, B. R., Pepine, C. J., & Raizada, M. K. (2022) · Circulation Research · doi:10.1161/circresaha.121.319816 · Cited by 115
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Tesch, G. H., & Young, M. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00313 · Cited by 112
Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects
Robles‐Vera, I., Toral, M., de la Visitación, N., Sánchez, M., Gómez‐Guzmán, M., Muñoz, R., Algieri, F., Vezza, T., Jiménez, R., Gálvez, J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14965 · Cited by 112
Immunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 112
Multi-omics approaches for revealing the complexity of cardiovascular disease
Doran, S. F., Arif, M., Lam, S. C. C., Bayraktar, A., Türkez, H., Uhlén, M., Borén, J., & Mardinoğlu, A. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab061 · Cited by 113
Xu, J., Moore, B. N., & Pluznick, J. L. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18558 · Cited by 119
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 117
Wang, S., Ren, H., Zhong, H., Zhao, X., Li, C., Ma, J., Gu, X., Xue, Y., Huang, S., Yang, J., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2003176 · Cited by 110
Nakai, M. E., Ribeiro, R. V., Stevens, B. R., Gill, P. A., Muralitharan, R. R., Yiallourou, S. R., Muir, J. G., Carrington, M. J., Head, G. A., Kaye, D. M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17288 · Cited by 107
Self-citationHsu, C., & Tain, Y. (2019) · Nutrients · doi:10.3390/nu11040894 · Cited by 108
Gut microbiome mediates the protective effects of exercise after myocardial infarction
Zhou, Q., Deng, J., Pan, X., Meng, D., Zhu, Y., Bai, Y., Shi, C., Duan, Y., Wang, T., Li, X., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01271-6 · Cited by 110
Lee, K. W., Loh, H. C., Ching, S. M., Devaraj, N. K., & Hoo, F. K. (2020) · Nutrients · doi:10.3390/nu12061604 · Cited by 105
Toral, M., Robles‐Vera, I., de la Visitación, N., Romero, M., Sánchez, M., Gómez‐Guzmán, M., Rodríguez‐Nogales, A., Yang, T., Jiménez, R., Algieri, F., et al. (2019) · Acta Physiologica · doi:10.1111/apha.13285 · Cited by 105
RetractedBlood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease
Velmurugan, G., Dinakaran, V., Rajendhran, J., & Swaminathan, K. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.013 · Cited by 108
Fernández‐López, J., Viuda‐Martos, M., Sayas‐Barberá, E., Navarro, C., & Pérez‐Álvarez, J. Á. (2022) · Agronomy · doi:10.3390/agronomy12040876 · Cited by 104
Evaluation of Prebiotic Potential of Three Marine Algae Oligosaccharides from Enzymatic Hydrolysis
Han, Z., Yang, M., Fu, X., Chen, M., Su, Q., Zhao, Y., & Mou, H. (2019) · Marine Drugs · doi:10.3390/md17030173 · Cited by 106
Jama, H. A., Beale, A. L., Shihata, W., & Marques, F. Z. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz091 · Cited by 105
Self-citationUraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
Ravid, J. D., Kamel, M. H., & Chitalia, V. C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00408-4 · Cited by 102
Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
Lu, Y., Zhang, Y., Zhao, X., Shang, C., Xiang, M., Li, L., & Cui, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900381 · Cited by 120
Mamic, P., Chaikijurajai, T., & Tang, W. H. W. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.12.001 · Cited by 100
Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure
Snelson, M., Muralitharan, R. R., Liu, C., Markó, L., Forslund, S. K., Marques, F. Z., & Tang, W. H. W. (2025) · Circulation Research · doi:10.1161/circresaha.125.325516 · Cited by 118
Self-citationHigh Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
Singh, G. B., Zhang, Y., Boini, K. M., & Koka, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143570 · Cited by 103
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
D’Haens, G., & Jobin, C. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.053 · Cited by 104
A major mechanism for immunomodulation: Dietary fibres and acid metabolites
Xie, L., Alam, J., Marques, F. Z., & Mackay, C. R. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101737 · Cited by 101
Self-citationCheema, M. U., & Pluznick, J. L. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13155 · Cited by 93
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Chen, X., Zhang, H., Ren, S., Ding, Y.-N., Remex, N. S., Bhuiyan, M. S., Qu, J.-H., & Tang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002206 · Cited by 101
Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)
Hemmati, M., Kashanipoor, S., Mazaheri, P., Alibabaei, F., Babaeizad, A., Asli, S., Mohammadi, S., Gorgin, A. H., Ghods, K., Yousefi, B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121947 · Cited by 105
Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
Callejo, M., Mondéjar‐Parreño, G., Barreira, B., Izquierdo-García, J. L., Morales‐Cano, D., Esquivel‐Ruiz, S., Moreno, L., Cogolludo, A. L., Duarte, J., & Pérez‐Vizcaíno, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-27682-w · Cited by 96
Robles‐Vera, I., Toral, M., de la Visitación, N., Sánchez, M., Romero, M., Olivares, M. M., Jiménez, R., & Duarte, J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800298 · Cited by 95
Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels
Jaworska, K., Koper, M., & Ufnal, M. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00099.2021 · Cited by 93
Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
May, K. S., & den Hartigh, L. J. (2023) · Nutrients · doi:10.3390/nu15020272 · Cited by 100
Hsu, C., Chang‐Chien, G., Lin, S., Hou, C., & Tain, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900073 · Cited by 95
Diet-gut microbiota interactions on cardiovascular disease
Zhang, X., & Gérard, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.028 · Cited by 98
A cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 95
Busnelli, M., Manzini, S., & Chiesa, G. (2019) · Nutrients · doi:10.3390/nu12010079 · Cited by 92
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Huang, Y., Xin, W., Xiong, J., Yao, M., Zhang, B., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837500 · Cited by 93
Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury
Wang, H., Wang, Q., Yang, C., Guo, M., Cui, X., Jing, Z., Liu, Y., Qiao, W., Qi, H., Zhang, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2027853 · Cited by 87
Awoyemi, A., Mayerhofer, C. C. K., Felix, A. S., Hov, J. R., Moscavitch, S. D., Lappegård, K. T., Hovland, A., Halvorsen, S., Halvorsen, B. L., Gregersen, I., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103511 · Cited by 88
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Sircana, A., Michieli, F. D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D., & Musso, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.013 · Cited by 87
Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
Yoo, J. Y., Sniffen, S. E., Percy, K. C. M., Chidipi, B., & Pallaval, V. B. (2022) · Microorganisms · doi:10.3390/microorganisms10010108 · Cited by 88
Gut Microbiota Metabolites Sensed by Host GPR41/43 Protect Against Hypertension
Muralitharan, R. R., Zheng, T., Dinakis, E., Xie, L., Barbaro-Wahl, A., Jama, H. A., Nakai, M. E., Patterson, M., Leung, K. C., McArdle, Z. M., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325770 · Cited by 92
Self-citationChen, X., Li, H., Hu, X., Zhang, Y., & Zhang, S. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000330 · Cited by 84
Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?
Mashaqi, S., & Gozal, D. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7990 · Cited by 81
Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO
Poll, B. G., Cheema, M. U., & Pluznick, J. L. (2020) · Physiology · doi:10.1152/physiol.00004.2020 · Cited by 85
Microbiota in Gut‐Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease
Kondapalli, N. B., Katari, V., Dalal, K. K., Paruchuri, S. M., & Thodeti, C. K. (2025) · Comprehensive physiology · doi:10.1002/cph4.70024 · Cited by 98
Probiotic Bifidobacterium breve prevents DOCA‐salt hypertension
Robles‐Vera, I., de la Visitación, N., Toral, M., Sánchez, M., Romero, M., Gómez‐Guzmán, M., Yang, T., Izquierdo-García, J. L., Guerra-Hernández, E. J., Ruı́z-Cabello, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001532r · Cited by 83
The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
Forkosh, E., & Ilan, Y. (2019) · Open Heart · doi:10.1136/openhrt-2018-000993 · Cited by 86
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
Amedei, A., & Morbidelli, L. (2019) · Molecules · doi:10.3390/molecules24213992 · Cited by 84
The Implication of the Gut Microbiome in Heart Failure
Lupu, V. V., Răileanu, A. A., Mihai, C. M., Morariu, I. D., Lupu, A., Stârcea, I. M., Frăsinariu, O. E., Mocanu, A., Dragan, F., & Fotea, S. (2023) · Cells · doi:10.3390/cells12081158 · Cited by 89
Jama, H. A., Muralitharan, R. R., Xu, C., O’Donnell, J. A., Bertagnolli, M., Broughton, B. R. S., Head, G. A., & Marques, F. Z. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15650 · Cited by 85
Self-citationCarnagarin, R., Matthews, V. B., Zaldivia, M. T. K., Peter, K., & Schlaich, M. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14481 · Cited by 85
Fu, L., Zhang, G., Qian, S., Zhang, Q., & Tan, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.972399 · Cited by 85
Lucking, E. F., O’Connor, K. M., Strain, C., Fouhy, F., Bastiaanssen, T. F. S., Burns, D. P., Golubeva, A. V., Stanton, C., Clarke, G. A., Cryan, J. F., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.010 · Cited by 78
Zhou, Y., Xie, L., Schröder, J., Schuster, I. S., Nakai, M. E., Sun, G., Sun, Y., Mariño, E., Degli‐Esposti, M. A., Marques, F. Z., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0724-23.2023 · Cited by 80
Self-citationThe functional roles of short chain fatty acids as postbiotics in human gut: future perspectives
Ragavan, M. L., & Hemalatha, S. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01414-x · Cited by 86
Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension
Marques, F. Z., Jama, H. A., Tsyganov, K., Gill, P. A., Rhys-Jones, D. R., Muralitharan, R. R., Muir, J. G., Holmes, A. J., & Mackay, C. R. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13079 · Cited by 80
Self-citationWen, K., Tao, L., Tao, Z., Meng, Y., Zhou, S., Chen, J., Yang, K., Da, W., & Zhu, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.535310 · Cited by 77
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension
Zhong, H., Zeng, H.-L., Cai, Y.-L., Zhuang, Y.-P., Liou, Y., Wu, Q., & He, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.679624 · Cited by 79
The interplay between PCOS pathology and diet on gut microbiota in a mouse model
Paris, V. R., Wong, X. Y. D., Solon‐Biet, S. M., Edwards, M. C., Aflatounian, A., Gilchrist, R. B., Simpson, S. J., Handelsman, D. J., Kaakoush, N. O., & Walters, K. A. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2085961 · Cited by 83
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Bhargava, S., Merckelbach, E., Noels, H., Vohra, A., & Jankowski, J. (2022) · Toxins · doi:10.3390/toxins14100648 · Cited by 77
Hamjane, N., Mechita, M. B., Nourouti, N. G., & Barakat, A. (2023) · Microvascular Research · doi:10.1016/j.mvr.2023.104601 · Cited by 92
Poll, B. G., Xu, J., Jun, S., Sanchez, J., Zaidman, N. A., He, X., Lester, L., Berkowitz, D. E., Paolocci, N., Gao, W. D., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000187 · Cited by 76
Date Palm Fruit (Phoenix dactylifera): Effects on Vascular Health and Future Research Directions
Al-Dashti, Y. A., Holt, R. R., Keen, C. L., & Hackman, R. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094665 · Cited by 87
How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure
Xu, C., & Marques, F. Z. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01216-2 · Cited by 82
Self-citationRole of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Zhang, Z., Lv, T., Wang, X., Wu, M., Zhang, R., Yang, X., Fu, Y., & Liu, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116567 · Cited by 79
Probiotics: Protecting Our Health from the Gut
Varela-Trinidad, G. U., Domínguez-Díaz, C., Solórzano-Castanedo, K., Íñiguez-Gutiérrez, L., Hernández-Flores, T. D. J., & Fafutis‐Morris, M. (2022) · Microorganisms · doi:10.3390/microorganisms10071428 · Cited by 80
Local and systemic effects of microbiome‐derived metabolites
Spivak, I., Fluhr, L., & Elinav, E. (2022) · EMBO Reports · doi:10.15252/embr.202255664 · Cited by 75
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Samarraie, A. A., Pichette, M., & Rousseau, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065420 · Cited by 78
The oral-gut microbiota axis: a link in cardiometabolic diseases
Xu, Q., Wang, W., Li, Y., Cui, J., Zhu, M., Liu, Y., & Liu, Y. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00646-5 · Cited by 82
Tang, X., & de Vos, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2290230 · Cited by 76
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
Tsai, H.-J., Tsai, W., Hung, W., Hung, W., Chang, C.-C., Dai, C., & Tsai, Y. (2021) · Nutrients · doi:10.3390/nu13082679 · Cited by 75
Smoking-induced microbial dysbiosis in health and disease
Shapiro, H., Goldenberg, K., Ratiner, K., & Elinav, E. (2022) · Clinical Science · doi:10.1042/cs20220175 · Cited by 77
The central role of the gut in intensive care
Corriero, A., Gadaleta, R. M., Puntillo, F., Inchingolo, F., Moschetta, A., & Brienza, N. (2022) · Critical Care · doi:10.1186/s13054-022-04259-8 · Cited by 78
Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure
Kamo, T., Akazawa, H., Suzuki, J.-I., & Komuro, I. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0028 · Cited by 73
The role of the gut microbiome in sex differences in arterial pressure
Beale, A. L., Kaye, D. M., & Marques, F. Z. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0236-8 · Cited by 72
Self-citationThe Gut Microbiome as a Therapeutic Target for Cognitive Impairment
Sun, Y., Baptista, L. C. P., Roberts, L. M., Jumbo-Lucioni, P., McMahon, L. L., Buford, T. W., & Carter, C. S. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz281 · Cited by 73
Metadata
- Authors
- Marques, F. Z., Nelson, E., Chu, P.-Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J. K., Kuruppu, S., Rajapakse, N. W., El-Osta, A., Mackay, C. R., & Kaye, D. M.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.) and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne, Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences (F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T., S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash...
- ORCID
- Venue
- Circulation
- Published
- 2017-03-07
- Volume
- 135
- Issue
- 10
- Pages
- 964-977
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2560340862
- Cited by
- 1,065
- References
- 47
- Citations by year
- 2026: 95 · 2025: 142 · 2024: 137 · 2023: 136 · 2022: 148 · 2021: 144 · 2020: 101 · 2019: 77 · 2018: 56 · 2017: 29
- FWCI
- 28.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- State Government of Victoria
- Baker Heart and Diabetes Institute
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- high-fiber diet, acetate supplementation, gut microbiota, hypertension, heart failure, mineralocorticoid excess, Bacteroides acidifaciens, Firmicutes/Bacteroidetes ratio, myocardial fibrosis, left ventricular hypertrophy, renal fibrosis, EGR1, circadian rhythm, renin-angiotensin system, MAPK signaling, short-chain fatty acids, cardiovascular disease prevention
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Blood Pressure, Dietary Fiber, Disease Models, Animal, Fibrosis, Hypertension, Kidney, Male, Mice, Inbred C57BL, Myocardium, Organ Size, RNA, Ribosomal, 16S, Dietary Supplements, Principal Component Analysis, Gastrointestinal Tract, Mice, Transcriptome, Desoxycorticosterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
